Prevalence of knee OA lower with menopausal hormone therapy

Prevalence of knee OA lower with menopausal hormone therapy

(HealthDay)—For postmenopausal women, the prevalence of knee osteoarthritis is lower with menopausal hormone therapy (MHT) use, according to a study published online Dec. 21 in Menopause.

Jae Hyun Jung, M.D., Ph.D., from the Korea University College of Medicine in Seoul, and colleagues collected data from 4,766 from the Korea National Health and Nutrition Examination Survey (2009 to 2012). MHT was defined as use of regular hormone medication for one year or more; the correlation between prevalence of OA and MHT was examined.

The researchers found that the odds ratio for OA was 0.7 for the MHT group versus the non-MHT group in the multiple logistic regression models.

"This cross-sectional study precludes conclusions about causal relationships, so further prospective studies and intervention trials should be undertaken to establish a causal association between knee OA and MHT," the authors write.

Explore further

Hormone therapy may be best defense against knee osteoarthritis

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: Menopause

Copyright © 2019 HealthDay. All rights reserved.

Citation: Prevalence of knee OA lower with menopausal hormone therapy (2019, January 17) retrieved 21 September 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more